New Era of Electrodes for High-Precision Patient Care.
Mukava Biosignals Oy’s patented electrode technology is built for precision, comfort, and convenience in long- and short-term use.
Mukava
Shaping the Future of Electrode Experience
Mukava Biosignals Oy a Finnish medtech start-up and spin-off from VTT Technical research centre Ltd. has specialized in developing innovative signal measurement technologies that enhance healthcare and wellness solutions.
Backed by over 3 years of intensive research, Mukava Biosignals Oy is soon lauching advanced dry electrode technology platform delivering outstanding signal quality, reliability and comfort.
Mukava Biosignals Oy currently focuses on launching MUKAVA C45 ECG electrode. The electrode technology is suitable also for future clinical applications such as EEG, EMG, and EOG that are in the pipeline.
Founders
Technology
Introducing MUKAVA C45
A Next-Generation Gel-Free ECG electrode providing superior comfort, convenience, & high-precision in ECG measurements.
Enhanced Comfort
Mukava electrodes are thin, flexible and, breathable making them unnoticeable.
Enhanced Accuracy
Mukava electrodes provide improved signal quality improving ECG signal analysis.
Irritation Free Materials
Mukava electrodes don’t contain gel and has reduced adhesive volume.
Breathability
Mukava electrodes are breathable making them sweat resistant staying in place even in extreme conditions.
Sustainability
Mukava Electrodes provide sustainable lifetime value through improved materials.